Sophia Genetics bags $77M Series E, with 850+ hospitals signed up to its ‘data-driven medicine’

By January 4, 2019 April 4th, 2019 Portfolio
Sophia Genetics CEO

Another sizeable cash injection for big data biotech: Sophia Genetics has announced a $77 million Series E funding round, bringing its total raised to $140 million since the business was founded back in 2011.

The company, which applies AI to DNA sequencing to enable what it dubs “data-driven medicine,” last closed a $30 million Series D in fall 2017.

Techcrunch